dr. hellmann on the design of the checkmate-032 study for lung cancer
Published 7 years ago • 338 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
1:02
dr. hellmann on nivolumab in combination with ipilimumab for small cell lung cancer
-
1:44
dr. liu on the checkmate-032 trial in sclc
-
1:11
dr. hellmann on tumor mutational burden testing in patients with lung cancer
-
0:18
copy of dr. hellmann on tumor mutational burden testing in patients with lung cancer
-
1:16
dr. ott on the checkmate-032 study in gastric and gej cancer
-
0:56
dr. hellmann on tumor mutational burden in nsclc
-
2:09
checkmate 032: nivolumab/ipilimumab for urothelial carcinoma
-
3:20:57
high yield shelf and usmle review: cardiology and pulm
-
1:01
dr. heymach on nivolumab for lung cancer
-
1:52
dr. drilon on the utility of brigatinib in alk nsclc
-
1:58
dr. heymach discusses the checkmate-026 study in lung cancer
-
2:04
george simon, md, facp, fccp, on the checkmate 032 & ctong 1104 nsclc studies presented at asco
-
1:19
dr. kelly on the rationale for the checkmate-577 trial in esophageal/gej cancer
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
1:41
dr. heymach on the significance of nivolumab for lung cancer
-
2:35
checkmate-816: what does the data tell us?
-
0:50
dr. drilon on comprehensive sequencing in lung cancer
-
3:17
nivolumab with ipilimumab for small cell lung cancer
-
3:23
surgical outcomes from the phase iii checkmate 816 trial